We use essential cookies (authentication, your saved goals/stack) by default. With your permission we’ll also enable privacy-respecting analytics (Vercel Web Analytics, anonymous load-time metrics) and error-replay diagnostics (Sentry — DOM snapshots only when an error fires) so we can fix bugs faster. Learn more about cookies
SNAP-8 (acetyl octapeptide-3 / acetyl glutamyl heptapeptide-1)
A topical 'anti-wrinkle' cosmetic peptide (acetyl octapeptide-3), an elongated relative of argireline that is marketed to relax expression lines by mimicking a SNARE-complex fragment. Honest appraisal: independent human evidence for SNAP-8 specifically is minimal; most support is manufacturer data and extrapolation from argireline. A topical cosmetic ingredient, not a supplement or drug.
Topical cosmetic peptide — not a dietary supplement
SNAP-8 is a topical cosmetic ingredient, not a supplement you take internally and not a drug. It is sold legally in skincare products to affect the appearance of skin (such as wrinkles). The evidence below comes mostly from small, often industry-funded studies of topical application, so treat the effect sizes cautiously. This page is for transparency and education, not a recommendation.
What the evidence says
Most SNAP-8 studies are mechanism or observational rather than RCTs that measure a clinical effect — keep findings provisional.
Most evidence is from mixed-quality randomised trials published 2010–2022.
Based on 5 studies · 1 RCT
Confidence
Low confidenceBy outcome
Independent human evidence for SNAP-8 specifically is minimal — most support is manufacturer data, formulation papers, and extrapolation from the better-studied argireline; poor skin permeability limits real-world wrinkle effects, so the evidence is weak and indirect.
SNAP-8 (acetyl octapeptide-3) is a topical cosmetic peptide patterned on the N-terminal end of SNAP-25, a protein in the SNARE complex that mediates neurotransmitter (acetylcholine) release at the neuromuscular junction.
It is an elongated analog of argireline (acetyl hexapeptide-3/-8) and is marketed on the same premise: that by competing with SNAP-25 in SNARE assembly it modestly reduces the muscle contractions that cause expression wrinkles — a topical, far weaker, needle-free analogy to botulinum toxin.
The honest evidence picture is that rigorous, independent human efficacy data for SNAP-8 specifically are sparse; the better-controlled cosmetic-peptide trial evidence is for argireline, and much SNAP-8 support comes from manufacturer studies, formulation papers, and reviews.
A central limitation for all such peptides is skin permeability — these are relatively large, hydrophilic molecules that penetrate the stratum corneum poorly, so real-world effect sizes on wrinkles are small and depend heavily on formulation and delivery.
SNAP-8 is regulated as a cosmetic ingredient sold for appearance, not a dietary supplement or a drug; it is applied topically and is generally well tolerated. The score reflects small, mostly indirect/topical evidence.
SNAP-8 mimics the N-terminus of SNAP-25 and is proposed to compete in SNARE-complex assembly, modestly reducing acetylcholine release and muscle contraction in expression lines.
By dampening micro-contractions in superficial facial muscles it is marketed to soften dynamic wrinkles — a far weaker, topical analogy to neuromodulator injections.
How SNAP-8 works — from molecular targets to health outcomes. Click an edge to see supporting research.This visualization is in beta — pathways are being refined and expanded.
Patch-test first; topical peptides are generally well tolerated but irritation is possible.
Likely low risk topically given minimal absorption, but specific data are lacking — discuss with a clinician.
Manage expectations — topical effect is far smaller than neuromodulator injections.
Tip: Topical peptides are generally well tolerated; patch-test if sensitive.
The current evidence for SNAP-8 is insufficient to assign an evidence score, based on 5 indexed studies. A topical 'anti-wrinkle' cosmetic peptide (acetyl octapeptide-3), an elongated relative of argireline that is marketed to relax expression lines by mimicking a SNARE-complex fragment. Honest appraisal: independent human evidence for SNAP-8 specifically is minimal; most support is manufacturer data and extrapolation from argireline. A topical cosmetic ingredient, not a supplement or drug. Representative study: PMID 23417317.
The commonly studied dose of SNAP-8 is Topical cosmetic only — applied as formulated in a serum/cream (commonly ~3–10% of the supplier's peptide solution). Not ingested; not a supplement.. Individual needs vary — start at the lower end of the range and adjust based on how you respond.
Timing is flexible for SNAP-8 — consistent daily use matters more than the time of day. Topical skincare ingredient applied to the skin; not ingested or scheduled.
SNAP-8 is generally safe at recommended doses, with a few precautions worth noting. The most commonly reported side effects are local irritation. Use caution if any of these apply to you: Known hypersensitivity to the peptide or formulation.
Argireline
Mostly mechanism / observationalA topical cosmetic peptide — a leave-on skincare ingredient, NOT something you swallow, inject, or take as a supplement, and NOT a drug. Argireline (acetyl hexapeptide-8, also sold as acetyl hexapeptide-3) is a six-amino-acid fragment modelled on the SNAP-25 protein. It is marketed as 'topical Botox' because, in cell systems, it interferes with the SNARE complex that nerve endings use to release neurotransmitter, in theory slightly relaxing the tiny muscle contractions that create expression lines. There ARE real human topical studies — small, short, vehicle-controlled split-face wrinkle trials — and they do show modest reductions in the appearance of fine lines. But the effect sizes are small, several of the trials are industry-linked, and this is a cosmetic effect on wrinkle APPEARANCE, not a health outcome. It is generally well tolerated on skin. This entry exists to describe a cosmetic ingredient honestly, not to recommend an ingestible supplement.
Matrixyl
Mostly mechanism / observationalA topical cosmetic peptide — a leave-on skincare ingredient, NOT something you swallow, inject, or take as a supplement, and NOT a drug. Matrixyl is palmitoyl pentapeptide-4 (pal-KTTKS), a fatty-acid-attached fragment of type I collagen; the popular 'Matrixyl 3000' blend pairs palmitoyl tripeptide-1 with palmitoyl tetrapeptide-7. Rather than relaxing muscle like Argireline, Matrixyl is a 'signal peptide' marketed to nudge skin fibroblasts to make more collagen and extracellular matrix. There ARE real human topical studies — most notably a 12-week, double-blind, placebo-controlled, split-face trial that found modest but significant reductions in fine-line appearance — alongside in-vitro work showing it raises collagen/ECM genes. But the human effect sizes are small, several trials are industry-linked or null, and this is a cosmetic effect on skin APPEARANCE, not a health outcome. It is generally well tolerated on skin. This entry describes a cosmetic ingredient honestly, not an ingestible supplement.
Afamelanotide
Mostly mechanism / observationalA synthetic α-melanocyte-stimulating-hormone (α-MSH) analogue and melanocortin-1-receptor (MC1R) agonist that drives eumelanin production. IMPORTANT: distinguish two very different things. (1) The PRESCRIPTION DRUG afamelanotide (Scenesse) is a 16 mg subcutaneous implant placed by a clinician, FDA-approved (2019) and EMA-approved (2014) to prevent phototoxicity in adults with erythropoietic protoporphyria (EPP) — backed by genuine Phase 3 RCTs. (2) Grey-market 'melanotan I' injected for cosmetic tanning is the SAME molecule sold unregulated, of unknown purity/dose, and is unsafe — associated with mole/nevus changes and is not a supplement. This entry covers the drug honestly; it is not a recommendation to self-inject.
Melanotan-1
Mostly mechanism / observationalA grey-market injectable α-MSH analog sold for tanning ('the Barbie drug'). Chemically it is the SAME peptide as the approved drug afamelanotide (Scenesse). Honest appraisal: as an unregulated tanning injectable it has no efficacy/safety validation; its evidence base belongs to the regulated form for a rare blood disorder. Research-use-only.
Explore: Best supplements for Skin, Hair & Beauty
Reviewed by Dr. Baher Al Hakim · Last reviewed June 2026 · evidence from 5 studies · how we score · editorial policy
This information is for educational purposes only. It is not a substitute for professional medical advice. Always consult a qualified healthcare provider before starting, stopping, or changing any supplement or medication.
Tap node to isolate • Pinch to zoom • Tap edge for research